Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome
Clinical trial NCT03995108 · COMPLETED
Trial details
- NCT number
- NCT03995108
- Sponsor
- X4 Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2025-12-23
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.